ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 190 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $646,000 | -48.8% | 100,000 | -40.3% | 3.92% | -51.0% |
| Q1 2023 | $1,262,950 | -51.2% | 167,500 | -34.4% | 7.99% | -50.0% |
| Q4 2022 | $2,587,202 | -15.2% | 255,400 | -17.2% | 15.98% | -39.2% |
| Q3 2022 | $3,052,000 | -21.2% | 308,570 | -15.2% | 26.27% | -2.7% |
| Q2 2022 | $3,874,000 | +38.9% | 363,778 | +27.2% | 26.99% | +118.0% |
| Q1 2022 | $2,789,000 | -54.3% | 286,000 | -33.0% | 12.38% | -24.4% |
| Q4 2021 | $6,106,000 | -29.2% | 426,966 | -0.8% | 16.39% | -32.1% |
| Q3 2021 | $8,625,000 | – | 430,407 | – | 24.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |